FDA Anti-infective drugs clinical guidelines
Originally written in 1977, the guidelines will be reviewed and updated by the Infectious Diseases Society of America. Commissioner Young noted the update in a speech given at Bayer AG-Perspectives in Anti-infective Therapy meeting held Sept. 3 in Washington, DC.
You may also be interested in...
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.